Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

08 December 2022: Clinical Research

Predicting Chemotherapy Resistance in Gestational Trophoblastic Neoplasia: Ratio of Neutrophils, Lymphocytes, Monocytes, and Platelets

Gatot Nyarumenteng Adhipurnawan Winarno 1ABCDEF* , Ayu Insafi Mulyantari 1ABCDEF , Andi Kurniadi 1BD , Dodi Suardi 1BD , Zulvayanti Zulvayanti 1BD , Nurvita Trianasari 2C

DOI: 10.12659/MSM.938499

Med Sci Monit 2022; 28:e938499

Table 4 Comparison of combination of FIGO score, NLR, LMR, and PLR with chemotherapy outcome in high-risk GTN at Hasan Sadikin Hospital.

CombinationHigh riskp value
ChemoresistanceN=29ChemosensitiveN=34
 Mean±Std17.07±6.27316.71±8.530
 Median16.0015.00
 Range (min–max)7.00–40.007.00–44.00
 Mean±Std25.24±10.11914.32±8.796
 Median28.0011.00
 Range (min–max)7.00–40.007.00–32.00
 Mean±Std17.38±7.98416.53±8.184
 Median16.0016.00
 Range (min–max)7.00–40.007.00–36.00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750